Full Coverage

DOR BioPharma, Inc.: DOR BioPharma Opens New Corporate Office in United Kingdom

                   
marketwire.com
May 23, 2008
        
Story Timeline:  196 days

EWING, NJ (MARKET WIRE) DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents,... [read full story]                    

Add Comment
Latest article on this story:

DOR BioPharma Opens UK Office

 orglex.com May 23, 2008
First article on this story:

DOR BioPharma Provides Update on orBec European Regulatory and Development Strategy

 pharmiweb.co.uk May 22, 2008
Selected publications with coverage of this story:
redorbit.com orglex.com marketwire.com yahoo.com newsblaze.com pharmiweb.co.uk tmcnet.com
RELATED
Found 6 documents:

DOR BioPharma Opens UK Office

orglex.com
May 23, 2008
        

DOR BioPharma has opened a new corporate office in the UK. The new office gives DOR a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based in the UK. Serving as the company's official interface for regulatory interactions within...

                   

DOR BioPharma Opens New Corporate Office in United Kingdom

redorbit.com
May 23, 2008
        

Posted on: Friday, 23 May 2008, 09:00 CDT DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain...

DOR BioPharma Opens New Corporate Office in United Kingdom (Marketwire)

yahoo.com
May 23, 2008
        

EWING, NJ--(MARKET WIRE)--May 23, 2008 -- News ) ("DOR" or the "Company"), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced...

                   

DOR BioPharma Opens New Corporate Office in United Kingdom

newsblaze.com
May 23, 2008
        

DOR BioPharma, Inc. , a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced today that it

Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for DOR BioPharma, Inc. (OTCBB:DORB)...

tmcnet.com
May 23, 2008
        

AUSTIN, TX -- DOR BioPharma, Inc. (OTCBB:DORB), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain bioterrorism agents, announced recently that it has opened a...

                   

DOR BioPharma Opens New Corporate Office in United Kingdom

marketwire.com
May 23, 2008
        

EWING, NJ--(Marketwire - May 23, 2008) - DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against certain...